These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17065024)

  • 1. A subtype of aggressive B-cell lymphoma with an unusual presentation of effusion without masses.
    Kamihira S; Jiann C; Uemura A; Tsuruda K; Hasegawa H; Sugahara K; Yamada Y
    Leuk Lymphoma; 2006 Sep; 47(9):1991-3. PubMed ID: 17065024
    [No Abstract]   [Full Text] [Related]  

  • 2. Does the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations?
    Mationg-Kalaw E; Tan LH; Tay K; Lim ST; Tang T; Lee YY; Tan SY
    Histopathology; 2012 Dec; 61(6):1214-8. PubMed ID: 23171357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis.
    Li S; Desai P; Lin P; Yin CC; Tang G; Wang XJ; Konoplev SN; Khoury JD; Bueso-Ramos CE; Medeiros LJ
    Histopathology; 2016 Jun; 68(7):1090-8. PubMed ID: 26426741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunophenotypic and molecular study of primary large B-cell lymphoma of bone.
    Huebner-Chan D; Fernandes B; Yang G; Lim MS
    Mod Pathol; 2001 Oct; 14(10):1000-7. PubMed ID: 11598170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of microdissection and polymerase chain reaction for the detection of immunoglobulin gene rearrangement and translocation in primary intraocular lymphoma.
    Shen DF; Zhuang Z; LeHoang P; Böni R; Zheng S; Nussenblatt RB; Chan CC
    Ophthalmology; 1998 Sep; 105(9):1664-9. PubMed ID: 9754175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular-cytogenetic characterization of non-Hodgkin's lymphoma with double and cryptic translocations of the immunoglobulin heavy chain gene.
    Kanda-Akano Y; Nomura K; Fujita Y; Horiike S; Nishida K; Nagai M; Miura I; Nakamura S; Seto M; Iida S; Ueda R; Taniwaki M
    Leuk Lymphoma; 2004 Aug; 45(8):1559-67. PubMed ID: 15370207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and clinical features of non-Burkitt's, diffuse large-cell lymphoma of B-cell type associated with the c-MYC/immunoglobulin heavy-chain fusion gene.
    Akasaka T; Akasaka H; Ueda C; Yonetani N; Maesako Y; Shimizu A; Yamabe H; Fukuhara S; Uchiyama T; Ohno H
    J Clin Oncol; 2000 Feb; 18(3):510-18. PubMed ID: 10653866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EBV-positive high-grade B-cell lymphoma with MYC and BCL6 rearrangements.
    Craig A; Wen KW
    Blood; 2022 Jul; 140(4):406. PubMed ID: 35900784
    [No Abstract]   [Full Text] [Related]  

  • 9. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A; Chadburn A; Knowles DM
    Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements: Clinicopathologic Features of 11 Cases.
    Wang W; Hu S; Lu X; Young KH; Medeiros LJ
    Am J Surg Pathol; 2015 Aug; 39(8):1132-9. PubMed ID: 25828391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediastinal large B-cell lymphoma: new evidence in support of its distinctive identity.
    Chan JK
    Adv Anat Pathol; 2000 Jul; 7(4):201-9. PubMed ID: 10907805
    [No Abstract]   [Full Text] [Related]  

  • 12. High-grade B-cell lymphoma with MYC and BCL2 rearrangements presenting as a cervical mass.
    Lin C; Kuma L; Shen L
    Pathology; 2024 Jun; 56(4):588-590. PubMed ID: 37940480
    [No Abstract]   [Full Text] [Related]  

  • 13. MYC rearranged B-cell neoplasms: Impact of genetics on classification.
    Haberl S; Haferlach T; Stengel A; Jeromin S; Kern W; Haferlach C
    Cancer Genet; 2016 Oct; 209(10):431-439. PubMed ID: 27810071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous involvement of high-grade B-cell lymphoma with MYC and BCL6 rearrangements: A case report.
    Maejima E; Oishi N; Ogawa Y; Okamoto T; Mitsui H; Shimada S; Kawamura T
    J Dermatol; 2023 Aug; 50(8):e243-e244. PubMed ID: 36890662
    [No Abstract]   [Full Text] [Related]  

  • 15. Translocation (3;16)(q27;p11) in a patient with diffuse large B-cell lymphoma associated with the BCL-6 gene rearrangement.
    Ichinohasama R; Miura I; Shishido T; Matsumoto K; Shimizu Y; Miki T; DeCoteau JF; Kadin ME; Ooya K
    Cancer Genet Cytogenet; 1998 Jun; 103(2):133-9. PubMed ID: 9614912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis.
    Li S; Weiss VL; Wang XJ; Desai PA; Hu S; Yin CC; Tang G; Reddy NM; Medeiros LJ; Lin P
    Am J Surg Pathol; 2016 Feb; 40(2):253-61. PubMed ID: 26448193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of C-MYC in the spectrum of transformed follicular lymphoma grade 3b.
    Tzankov A; Höllrigl A; Verdorfer I; Oxle H
    Hum Pathol; 2007 Jan; 38(1):191-2; author reply 192-3. PubMed ID: 17169631
    [No Abstract]   [Full Text] [Related]  

  • 18. Genomic profile of TdT
    Hamdan H; Luu L; Opsahl M; Weinberg O; Fuda F; Koduru P; Wilson K; Gagan J; Ramakrishnan Geethakumari P; Collins R; Chen W
    Cytometry B Clin Cytom; 2022 Nov; 102(6):448-450. PubMed ID: 36102633
    [No Abstract]   [Full Text] [Related]  

  • 19. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
    Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomorphologic findings of B-cell lymphomas with concurrent IGH/BCL2 and MYC rearrangements (dual-translocation lymphomas).
    da Cunha Santos G; Ko HM; Saieg MA; Boerner SL; Lai SW; Bailey D; Geddie WR
    Cancer Cytopathol; 2011 Aug; 119(4):254-62. PubMed ID: 21560251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.